Addressing Disparities in Cancer Care and Beyond: What Can Be Done Now?ByAlexander J. AlvarnasOctober 12th 2021
Dr David S. Hong: We Are Learning Every Day About Cellular TherapiesByMaggie L. ShawOctober 12th 2021
Conversations on CAR T: Study of Checkpoint Inhibitors After Transplant Bolsters Case for CAR T, Skarbnik SaysByMary CaffreyOctober 11th 2021
Conversations on CAR T: UAB’s Mehta Discusses Opportunities and ChallengesByMary CaffreyOctober 11th 2021
The Promise of Liquid Biopsies for Cancer DiagnosisByLiz Kwo, MD, MBA, MPH,Jenna AronsonOctober 11th 2021
Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler SaysByDenise MyshkoOctober 11th 2021
Abstracts at ASCO Quality Show Uptake of Rapid NGS, Biomarker Testing Across OneOncology ByAJMC StaffOctober 4th 2021
